Intrinsic Value of S&P & Nasdaq Contact Us

Teleflex Incorporated TFX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
$142.15
+13.5%
Analyst Price Target
$133.25
+6.4%

Teleflex Incorporated (TFX) generated $340.68M in operating cash flow for fiscal year 2025. After capital expenditures of $95.24M, free cash flow was $245.44M.

Free cash flow margin was 12.3% of revenue. Cash conversion ratio was 5.82x, indicating earnings are backed by cash.

The company returned $60.27M in dividends and $300M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (70/100, Pass) — $245.44M (12.3% FCF margin) supports a durable competitive advantage
  • INCOME (10/100) — Cash conversion ratio was 5.82x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 48/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
48/100
SG Score
View full scorecard →
VALUE
78/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
40/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
70/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
Teleflex Incorporated Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $340.68M$340.68M$635.74M$510.64M$342.14M
Capital Expenditure $-65.23M$-95.24M$-126.43M$-91.44M$-79.19M
Free Cash Flow $245.44M$245.44M$509.31M$419.2M$262.95M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message